Sequencing Service to Support Gene Therapy Research
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- FDA-RFQ-1255498
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Silver Spring, Maryland 20903, United States
Notice details come from SAM.gov. Updated .
Notice text
2 versions
Update #2 · Latest ·
09/07/2022: Amendment No. 1 issued responding to questions received. Questions & Answers enclosed as Attachment No: 3.
********************************************************************************************************************************************
This requirement is to provide sequencing services on purified human genomic DNA samples.
Please see enclosed RFQ for full details.
Update #1 ·
This requirement is to provide sequencing services on purified human genomic DNA samples.
Please see enclosed RFQ for full details.
Files
| File | Type | Posted |
|---|---|---|
| Sol_Doc_Amend No.1.pdf | ||
| Attachment No. 3 - Questions Answers.pdf | ||
| Attachment No. 1 - FAR Class Deviation 2020-05.pdf | ||
| Attachment No. 2 - HHS Class Deviation 2020-20.docx | DOCX document | |
| Sol_Doc .pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Sequencing Service to Support Gene Therapy Research | Award Notice | |
| This notice | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity